Amlodipine, a calcium channel inhibitor, and cocaine and ethanol's reinforcing effects

Pharmacology Biochemistry and Behavior

Volumn 64, Issue 3, 1999, Pages 567-572

  Gardell, Luis R ^a   Reid, Meta L ^a   Cavallero, Colleen A ^a   Burgess, Shannon E ^a   Wallace, Roland F ^a   Hubbell, Christopher L ^a   Reid, Larry D ^a  

^a RENSSELAER POLYTECHNIC INSTITUTE   (United States)

Author keywords

Amlodipine; Brain stimulation reward; Calcium channel inhibitors; Cocaine; Ethanol; Isradipine; Medications for alcoholism; Medications for cocaine; Polydrug abuse

Indexed keywords

ALCOHOL; AMLODIPINE; CALCIUM; CALCIUM CHANNEL BLOCKING AGENT; COCAINE; ISRADIPINE; NALTREXONE; PLACEBO;

ALCOHOL CONSUMPTION; ALCOHOLISM; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG ABUSE; DRUG EFFECT; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

AMLODIPINE; ANIMALS; BLOOD PRESSURE; CALCIUM CHANNEL BLOCKERS; CALCIUM CHANNELS, L-TYPE; CENTRAL NERVOUS SYSTEM DEPRESSANTS; COCAINE; DOPAMINE UPTAKE INHIBITORS; ETHANOL; ISRADIPINE; MALE; RATS; RATS, SPRAGUE-DAWLEY; REINFORCEMENT (PSYCHOLOGY);

EID: 0032830105     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-3057(99)00129-X     Document Type: Article

References (23)

1. Brogden R.N., Sorkin E.M. Isradipine. An update of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy in the treatment of mild to moderate hypertension Drug Eval. 49:1995;618-649.
2. Colombo G., Agabio R., Lobina C., Reali R., Fadda F., Gessa G.L. Blockade of ethanol discrimination by isradipine. Eur. J. Pharmacol. 265:1994;167-170.
3. Cramer C.M., Gardell L.R., Boedeker K.L., Harris J.R., Hubbell C.L., Reid L.D. Isradipine combined with naltrexone persistently reduces the reward-relevant effects of cocaine and alcohol. Pharmacol. Biochem. Behav. 60:1998;345-356.
4. Cramer C.M., Hubbell C.L., Reid L.D. A combination of isradipine and naltrexone blocks cocaine's enhancement of a cocaine place preference. Pharmacol. Biochem. Behav. 60:1998;847-853.
5. Fadda F., Garau B., Colombo G., Gessa G.L. Isradipine and other calcium channel antagonists attenuate ethanol consumption in ethanol-preferring rats. Alcohol. Clin. Exp. Res. 16:1992;449-452.
6. Fratta W., Kuzmin A., Martellotta M.C., Gessa G.L. The calcium antagonist isradipine inhibits cocaine and morphine reinforcing properties in rats. Soc. Neurosci. Abstr: 17:1991;887.
7. Gardell L.R., Reid L.D., Boedecker K.L., Liakos T.M., Hubbell C.L. Isradipine and naltrexone in combination with isradipine interact with a period of abstinence to reduce rats' intakes of an alcoholic beverage. Alcohol. Clin. Exp. Res. 21:1997;1592-1598.
8. Gonzales P.M., Boswell K.J., Hubbell C.L., Reid L.D. Isradipine blocks cocaine's ability to facilitate pressing for intracranial stimulation. Pharmacol. Biochem. Behav. 58:1997;1117-1122.
9. Haria M., Wagstaff A.J. Amlodipine A reappraisal of its pharmacological properties and therapeutic use in cardiovascular disease. Drugs. 50:1995;560-586.
10. Hubbell C.L., Czirr S.A., Hunter G.A., Beaman C.M., LeCAnn N.C., Reid L.D. Consumption of ethanol solution is potentiated by morphine and attenuated by naloxone persistently across repeated daily administrations. Alcohol. 3:1986;39-54.
11. Hubbell C.L., Reid L.D. Opioids modulate rats' intakes of alcohol beverages. Reid L.D. Opioids, bulimia, and alcohol abuse & alcoholism. 1990;145-174 Springer Verlag, New York.
12. Kuzmin A., Zvartau E., Gessa G.L., Martellotta M.C., Fratta W. Calcium antagonists isradipine and nimodipine suppress cocaine and morphine intravenous self-administration in drug-naive mice. Pharmacol. Biochem. Behav. 41:1992;497-500.
13. Martellotta M.C., Kuzmin A., Muglia P., Gessa G.L., Fratta W. Effects of the calcium antagonist isradipine on cocaine intravenous self-administration in rats. Psychopharmacology (Berlin). 113:1994;378-380.
14. Pabello N.G., Hubbell C.L., Cavallaro C.A., Barringer T.M., Mendez J.J., Reid L.D. Responding for rewarding brain stimulation. Cocaine and isradipine plus naltrexone Pharmacol. Biochem. Behav. 61:1998;181-192.
15. Pani L., Kuzmin A., Martellotta M.C., Gessa G.L., Fratta W. The calcium antagonist PN 200-110 inhibits the reinforcing properties of cocaine. Brain Res. Bull. 26:1991;445-447.
16. Reid L.D. Endogenous opioids and alcohol dependence. Opioid alkaloids and the propensity to drink alcoholic beverages Alcohol. 13:1996;5-11.
17. Reid L.D. Tests involving pressing for intracranial stimulation as an early procedure for screening likelihood of addiction of opioids and other drugs. Bozarth M.A. Methods of assessing the reinforcing properties of abused drugs. 1987;391-420 Springer Verlag, New York.
18. Reid L.D., Hubbell C.L. Opioids modulate rat's propensities to take alcoholic beverages. Naranjo C.A., Sellers E.M. Novel pharmacological interventions for alcoholism. 1992;121-134 Springer Verlag, New York.
19. Reid L.D., Pabello N.G., Cramer C.M., Hubbell C.L. Isradipine in combination with naltrexone as a medicine for treating cocaine abuse. Life Sci. 60:1997;PL119-PL126.
20. Rezvani A.H., Grady D.R., Janowsky D.S. Effect of calcium-channel blockers on alcohol consumption in alcohol-drinking monkeys. Alcohol Alcohol. 26:1991;161-167.
21. Rezvani A.H., Janowsky D.S. Decreased alcohol consumption by verapamil in alcohol preferring rats. Prog. Neuropsychopharmacol. Biol. Psychiatry. 14:1990;623-631.
22. ++ channel antagonists on alcohol preference in alcohol preferring rats. Alcohol. Clin. Exp. Res. 15:1991;314.
23. Schindler C.W., Tella S.R., Prada J., Goldberg S.R. Calcium channel blockers antagonize some of cocaine's cardiovascular effects, but fail to alter cocaine's behavioral effects. J. Pharmacol. Exp. Ther. 272:1995;791-798.